1-3 of 3
Nicolas Larmonier
Close
Sort by
Journal Articles

Preferential splenic CD8 + T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia

Sylvain Audia, Maxime Samson, Matthieu Mahévas, Christophe Ferrand, Malika Trad, Marion Ciudad, Alexandrine Gautheron, Famky Seaphanh, Vanessa Leguy, Sabine Berthier, Bruno Salles, Laurent Martin, Bernard Lorcerie, Pablo Ortega-Deballon, Olivier Facy, Denis Caillot, Agnès Soudry-Faure, Marc Michel, Bertrand Godeau, Nicolas Larmonier, Philippe Saas, Nona Janikashvili, Bernard Bonnotte
Journal: Blood
Blood (2013) 122 (14): 2477–2486.
https://doi.org/10.1182/blood-2013-03-491415
Published: 2013
Includes: Supplemental data
Journal Articles

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia

Sylvain Audia, Maxime Samson, Julien Guy, Nona Janikashvili, Jennifer Fraszczak, Malika Trad, Marion Ciudad, Vanessa Leguy, Sabine Berthier, Tony Petrella, Serge Aho-Glélé, Laurent Martin, Marc Maynadié, Bernard Lorcerie, Patrick Rat, Nicolas Cheynel, Emmanuel Katsanis, Nicolas Larmonier, Bernard Bonnotte
Journal: Blood
Blood (2011) 118 (16): 4394–4400.
https://doi.org/10.1182/blood-2011-03-344051
Published: 2011
Includes: Supplemental data
Journal Articles

Allogeneic effector/memory Th-1 cells impair FoxP3 + regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia

Nona Janikashvili, Collin J. LaCasse, Claire Larmonier, Malika Trad, Amanda Herrell, Sara Bustamante, Bernard Bonnotte, Michael Har-Noy, Nicolas Larmonier, Emmanuel Katsanis
Journal: Blood
Blood (2011) 117 (5): 1555–1564.
https://doi.org/10.1182/blood-2010-06-288621
Published: 2011
Includes: Supplemental data